GMC10
GMC10 is a selective MAP2K7 inhibitor with an IC50 of <1 nM for MAP2K7 and an IC50 of 340 nM for MAP2K4. GMC10 inhibits JNK pathway signaling. GMC10 enhances MRTX1133 (HY-134813)-induced Apoptosis. GMC10 can be used for research on pancreatic ductal adenocarcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C18H14FN3O3
- 分子量:339.32
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
MEK アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
MAP2K7/MEK7 <1 nM (IC50) |
MAP2K4/MEK4 340 nM (IC50) |
体外実験
GMC10 (0.1-1 μM; 24 h) inhibits Anisomycin (HY-18982)-induced JNK phosphorylation in parental KPC-2138 and CD18 PDAC cells at concentrations of 0.1 and 1 μM[1].
GMC10 inhibits pJNK[1] in parental and MRTX1133-tolerant PDAC cells during MRTX1133 exposure.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:parental mouse KPC-2138 and human CD18 PDAC cells
-
Concentration:0.1 and 1 μM
-
Incubation Time:24 h (figure legend); 5 h (Methods)
-
Result:Effectively suppressed anisomycin-induced JNK phosphorylation at both 0.1 and 1 μM in KPC-2138 and CD18 cells.
Demonstrated slightly superior efficacy among the tested lead compounds, with a dose-dependent decrease in anisomycin-induced pJNK.
化学情報
-
分子量 339.32
-
分子式 C18H14FN3O3
-
SMILES
O=C(OC)/C=C/C(NC1=CC=CC(C2=NNC3=C2C=CC(F)=C3)=C1)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
GMC10 関連分類
HY-189874 関連分類
Powered by Bioz